Cision PR Newswire

Akeso’s AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline

HONG KONG, Aug. 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its investigational next-generation B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received clinical trial clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). The clearance allows initiation of...

UNISOC Lyric Audio: Redefining the Listening Experience

SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- From voice calls to intelligent interaction, from music enjoyment to vlog creation, audio is no longer mere signal processing...

GAC Joins Chelsea Football Club as an Official Pre-Season Tour Partner in Hong Kong and Malaysia

KUALA LUMPUR, Malaysia, Aug. 5, 2026 /PRNewswire/ -- GAC is proud to be one of Chelsea FC's Official Pre-Season Tour Partners in Hong Kong and...

GAC Becomes an Official Pre-Season Tour Partner of Chelsea Football Club in Hong Kong and Malaysia

HONG KONG, Aug. 5, 2026 /PRNewswire/ -- GAC is proud to be one of Chelsea FC's Official Pre-Season Tour Partners in Hong Kong and...

Farmmi, Inc. Proposes to Acquire Brazilian Agricultural Supply Chain Company

LISHUI, China, Aug. 5, 2026 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (Nasdaq: FAMI) today announced that the Company has signed an acquisition...

So-Young Announces Appointment of Chief Financial Officer

BEIJING, Aug. 5, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers...